Correlation Between CytomX Therapeutics and Processa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Processa Pharmaceuticals, you can compare the effects of market volatilities on CytomX Therapeutics and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Processa Pharmaceuticals.
Diversification Opportunities for CytomX Therapeutics and Processa Pharmaceuticals
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between CytomX and Processa is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Processa Pharmaceuticals go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Processa Pharmaceuticals
Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 0.86 times more return on investment than Processa Pharmaceuticals. However, CytomX Therapeutics is 1.17 times less risky than Processa Pharmaceuticals. It trades about -0.04 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.29 per unit of risk. If you would invest 101.00 in CytomX Therapeutics on August 28, 2024 and sell it today you would lose (5.00) from holding CytomX Therapeutics or give up 4.95% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
CytomX Therapeutics vs. Processa Pharmaceuticals
Performance |
Timeline |
CytomX Therapeutics |
Processa Pharmaceuticals |
CytomX Therapeutics and Processa Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CytomX Therapeutics and Processa Pharmaceuticals
The main advantage of trading using opposite CytomX Therapeutics and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.CytomX Therapeutics vs. Eliem Therapeutics | CytomX Therapeutics vs. HCW Biologics | CytomX Therapeutics vs. Scpharmaceuticals | CytomX Therapeutics vs. Milestone Pharmaceuticals |
Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |